1st Quarter - Report — HUMANA, INC. for HUMANA INC (2020)

Firm

HUMANA, INC.

Client

HUMANA INC

Income

—

Expenses

$450,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Tricare Issues NDAA Implementation Issues H.R. 2500/S. 1790 National Defense Authorization Act of 2020

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DOUGLAS STOSS	—

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); SENATE; White House Office; Treasury, Dept of

Bills named: H.R. 2500 (116th), S. 1790 (116th)

Taxation/Internal Revenue Code TAX

Tax Reform Implementation Issues

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DOUGLAS STOSS	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Treasury, Dept of

Health Issues HCR

CMS-9115-P Interoperability and Patient Access Proposed Rule HHS ONC RIN-0955-AA01 -- 21st Century Cures Interoperability and Information Blocking Proposed Rule Senate HELP - Lower Health Care Costs Act S. 340/H.R. 965 CREATES Act H.R. 3630, No Surprises Act H.R. 2296, Fair Accountability and Innovative Research Act H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability, and Reporting Act H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act S. 1280/H.R. 2477, BENES Act H.R. 3, Lower Drug Costs Now Act of 2019 S. 2543, Prescription Drug Pricing Reduction Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020 H.R. 6201, Families First Coronavirus Response Act of 2020 H.R. 748/S. 3548, Coronavirus Aid, Recovery, and Economic Security (CARES) Act of 2020

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DOUGLAS STOSS	—

Contacted: Centers For Medicare and Medicaid Services (CMS); White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE; Treasury, Dept of

Bills named: H.R. 3630 (116th), H.R. 965 (116th), H.R. 987 (116th), S. 340 (116th), H.R. 2113 (116th), H.R. 748 (116th), H.R. 2296 (116th), H.R. 2477 (116th), S. 2543 (116th), H.R. 3 (116th), S. 1280 (116th), H.R. 6201 (116th), H.R. 6074 (116th), S. 3548 (116th)

Medicare/Medicaid MMM

Medicare Advantage Policy and Reimbursement 2021 Medicare Advantage Advance Rate Notice CMS 4190-P, 2021 and 2022 Policy and Technical Changes for Medicare Advantage, Part D, Medicaid, and PACE Proposed Rule Medicare Part D Issues CMS 4185-P Policy and Technical Changes in Medicare Advantage Program for 2020/2021 Medicaid and Dual Eligible Issues Pharmacy Reimbursement Issues Medicare Home Health Issues

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DOUGLAS STOSS	—

Contacted: Office of Management & Budget (OMB); White House Office; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Treasury, Dept of

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.